SynthesisFrontiers in medicine2026

Sacituzumab govitecan in metastatic breast cancer: a systematic review and meta-analysis of its clinical benefit and safety.

Zepeng Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.